🔍

Ritesh International Ltd (519097)

📊 BSE: 519097 🏢 Commodity Chemicals 📢 Latest filing: 14 Oct 2026

Q2 FY27 results

📅 Next results: 21 Oct 2026 (board meeting)

Ritesh International Ltd's board meets on 21 Oct 2026 to consider its Q2 FY27 results (July-September 2026).

In its latest reported quarter, Q1 FY27, Ritesh International's revenue was ₹50.5 Cr (+44.2% year on year, +3.7% on the previous quarter), and net profit ₹1.7 Cr (+358.9% year on year); the operating margin was 5.6%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹50.5	+44.2%	+3.7%
Operating profit	₹2.8	+192.3%	+35.0%
Net profit	₹1.7	+358.9%	+66.1%
EPS (₹)	1.86	+322.7%	+66.1%
Operating margin	5.6%	—	—

Full quarterly financials → Results calendar →

📢 Recent Corporate Announcements

Ritesh International Boards to Meet on Oct 21, 2026 to Approve Q2 FY27 Results

🟡 NEUTRAL ⭐ 3/10

BOARD_MEETING 📅 14 Oct 2026, 05:18 PM

Ritesh International Ltd has announced a board meeting scheduled for October 21, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026. The meeting will also review the Limited Review Report from statutory auditor Ashok Shashi & Co. The trading window for dealing in company securities remains closed from October 1, 2026, until 48 hours post result declaration. This is a standard regulatory intimation ahead of quarterly earnings.

Board meeting scheduled on October 21, 2026, at 02.00 p.m.
Agenda includes reviewing unaudited financial results for the quarter ended September 30, 2026
Limited Review Report to be submitted by statutory auditor Ashok Shashi & Co.
Trading window closure effective from October 1, 2026, until 48 hours after results announcement

💡 Track the financial performance on October 21, 2026, comparing top-line growth and operating margins against the preceding quarter's revenue of Rs 50.54 Cr.

Ritesh International Reappoints Ritesh Arora as Managing Director for 5-Year Term

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 30 Sep 2026, 04:43 PM

Ritesh International Ltd has announced the reappointment of Mr. Ritesh Arora as Managing Director for a tenure of 5 years, effective from December 14, 2026. The company operates in commodity chemicals with a market cap of Rs 80 Cr and TTM revenue of Rs 182 Cr. The move ensures leadership continuity for the firm, which has seen net profits improve to Rs 5 Cr over the trailing twelve months. Shareholder approval details and remuneration terms were not disclosed in the brief intimation.

Reappointment of Mr. Ritesh Arora (DIN: 00080156) as Managing Director
Tenure approved for a period of 5 years
Appointment effective date set from 14.12.2026
Filing executed under Regulation 30 of SEBI LODR Regulations 2015

💡 Track the upcoming AGM/postal ballot notices for shareholder approval and disclosures regarding executive remuneration terms.

Ritesh International Schedules AGM for Sept 28, 2026; Reappoints MD Ritesh Arora

🟡 NEUTRAL ⭐ 3/10

BOARD_MEETING 📅 29 Aug 2026, 08:04 PM

Ritesh International's Board of Directors approved key AGM-related resolutions in its meeting on August 29, 2026. The board approved the re-appointment of Mr. Ritesh Arora as Managing Director and a revision in remuneration for Wholetime Director Mr. Rijul Arora, subject to shareholder approval. The Annual General Meeting (AGM) is scheduled for September 28, 2026, with the register of members and share transfer books closing from September 23 to September 28, 2026. Additionally, statutory internal and cost auditors were appointed for FY 2026-27.

Annual General Meeting (AGM) scheduled for September 28, 2026, at 11:00 AM
Book closure period fixed from September 23, 2026, to September 28, 2026
Approved re-appointment of Mr. Ritesh Arora as Managing Director, subject to shareholder approval
Appointed CA Keshav Madaan as Internal Auditor and M/s Verma Khushwinder & Co. as Cost Auditor for FY 2026-27

💡 Track voting outcomes of the AGM on September 28, 2026, particularly regarding director reappointment and remuneration revisions.

Ritesh International announces 50% capacity expansion with ₹7 Cr capex

🟢 POSITIVE ⭐ 8/10

EXPANSION 📅 17 Aug 2026, 12:39 PM

Ritesh International has approved a 50% capacity expansion at its Ahmedgarh facility, raising daily production capacity from 80 MTPD to 120 MTPD. The estimated capital expenditure is ₹7.00 crore, which represents ~23.3% of the company's net worth (₹30 Cr), funded primarily via ₹6.00 crore in internal accruals and ₹1.00 crore in bank loans. The expansion is aimed at meeting surging demand for stearic acid, fatty acid, and glycerin as existing plants run near peak capacity. Commercial operations are targeted to commence in Q1 FY27-28 following an 8-month execution period.

Production capacity expanding 50% from 80 MTPD to 120 MTPD at Ahmedgarh facility
Total project capex estimated at ₹7.00 crore, financed via ₹6.00 crore internal accruals and ₹1.00 crore bank debt
Commercial operations targeted to commence by Q1 FY27-28 with an execution timeline of ~8 months
Addresses peak capacity utilization driven by domestic customer demand in stearic and fatty acids

💡 Track quarterly project execution progress and look for updates on commissioning timelines by Q1 FY27-28, along with volume ramp-up in subsequent quarters.

358% YoY PAT Growth to Rs 1.74 Cr; Revenue Up 44% in Q1 FY27

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 27 Jul 2026, 04:42 PM

Ritesh International reported a strong performance for the quarter ended June 30, 2026, with revenue from operations growing 44.2% YoY to Rs 50.54 Cr. Net profit surged 357.9% YoY to Rs 1.74 Cr, compared to Rs 0.38 Cr in the same period last year. This quarterly profit represents approximately 43% of the total TTM PAT, indicating a significant acceleration in earnings. The company also saw a sequential improvement in EPS to Rs 1.86 from Rs 1.12 in the preceding March quarter.

Revenue from operations increased 44.2% YoY to Rs 50.54 Cr from Rs 35.05 Cr.
Net Profit jumped 357.9% YoY to Rs 1.74 Cr from Rs 0.38 Cr.
Earnings Per Share (EPS) rose to Rs 1.86, up from Rs 0.44 in the year-ago quarter.
Profit Before Tax (PBT) reached Rs 2.34 Cr, a 392% increase over the June 2025 quarter.
Promoter holding increased significantly to 48.03% as of June 2026, up from 43.05% in March 2026.

💡 Investors should monitor the sustainability of these improved margins in the 'Non-edible Oils' segment and watch for any further increases in promoter stake which may signal internal confidence.

358% YoY PAT Growth: Ritesh International Reports Strong Q1 FY27 Results

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 27 Jul 2026, 04:37 PM

Ritesh International reported a robust performance for Q1 FY27, with revenue from operations growing 44.2% YoY to ₹50.54 Cr. Net profit surged by 358% YoY to ₹1.74 Cr, compared to ₹0.38 Cr in the same quarter last year. The company's EPS improved significantly to ₹1.86 from ₹0.44 YoY, reflecting strong operating leverage. This performance is notable for a micro-cap company with a market capitalization of just ₹70 Cr.

Revenue from operations increased 44.2% YoY to ₹50.54 Cr from ₹35.05 Cr.
Net profit jumped 358% YoY to ₹1.74 Cr, also showing a 65.7% sequential growth from ₹1.05 Cr in Mar 2026.
Earnings Per Share (EPS) rose to ₹1.86 for the quarter, up from ₹0.44 in the year-ago period.
Profit Before Tax (PBT) stood at ₹2.34 Cr, representing a 392% increase over the ₹0.48 Cr reported in Jun 2025.
The company operates in a single segment, Non-edible Oils, which drove the entire growth.

💡 Investors should monitor the sustainability of these improved margins in the coming quarters, as the business is concentrated in the commodity-linked non-edible oils segment.

Ritesh International Board Meeting on July 27, 2026, to Approve Q1 FY27 Results

🟡 NEUTRAL ⭐ 3/10

BOARD_MEETING 📅 21 Jul 2026, 07:58 PM

Ritesh International has scheduled a board meeting for July 27, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The company, a small-cap commodity chemical player with a market cap of Rs 64 Cr, reported a TTM revenue of Rs 167 Cr and a PAT of Rs 4 Cr. Investors will be monitoring if the company can sustain the revenue growth seen in the March 2026 quarter (Rs 48.75 Cr) compared to the June 2025 quarter (Rs 35.05 Cr). The trading window for insiders has been closed since July 1, 2026.

Board meeting scheduled for July 27, 2026, at 04:00 p.m. to approve Q1 results.
Trading window for insiders closed from July 1, 2026, until 48 hours post-result declaration.
Review of Unaudited Financial Results for the quarter ended June 30, 2026, by statutory auditors M/s Ashok Shashi & Co.
Company reported a TTM EPS of Rs 4.19 and an operating profit margin of 4.3%.

💡 Monitor the financial results on July 27, 2026, specifically focusing on whether the operating profit margin (OPM) improves from the current 4.3% and if the promoter holding increase (from 43.05% to 48.03% in June 2026) reflects in operational performance.

Ritesh International Board to meet on July 27, 2026, for Q1 FY27 results

🟡 NEUTRAL ⭐ 4/10

BOARD_MEETING 📅 21 Jul 2026, 07:52 PM

Ritesh International has scheduled a board meeting for July 27, 2026, to approve its unaudited financial results for the quarter ended June 30, 2026. The company enters this period with a TTM revenue of Rs 167 Cr and a market capitalization of Rs 64 Cr. Investors should note the significant 101% price return over the last 12 months and a recent increase in promoter holding to 48.03% as of June 2026. The trading window for insiders has been closed since July 1, 2026, in anticipation of these results.

Board meeting scheduled for July 27, 2026, to consider Q1 FY27 results.
Trading window for insiders closed from July 1, 2026, until 48 hours post-announcement.
Company reported a TTM revenue of Rs 167 Cr and PAT of Rs 4 Cr leading into this quarter.
Promoter holding increased by 4.98% during the June 2026 quarter to reach 48.03%.
Statutory auditors M/s Ashok Shashi & Co. to provide the Limited Review Report.

💡 Monitor the results on July 27 to see if the company maintains its operating profit margin, which stood at 4.3% on a TTM basis, and if revenue growth continues its upward trajectory from the previous four quarters.

View All 519097 Announcements on Live Market Tracking →